Focused Ultrasound for Tremor: What’s the Buzz?

Why It Matters

Focused ultrasound provides a durable, non‑surgical solution for medication‑refractory tremor, expanding access to effective therapy while reducing procedural risk and healthcare costs.

Key Takeaways

• MRI‑guided focused ultrasound treats medication‑refractory essential tremor non‑invasively.
• Five‑year data show ~74% tremor reduction and improved daily function.
• Common side effects: temporary numbness, imbalance; permanent in ~10% cases.
• Candidates must be ≥22, medication‑refractory, and have suitable skull density.
• Procedure covered by Medicare and most Blue‑Cross plans nationwide.

Summary

Johns Hopkins physicians presented a detailed overview of MRI‑guided focused ultrasound (FUS) as a non‑invasive treatment for essential tremor (ET). The webinar covered disease prevalence, diagnostic criteria, and the limitations of medications and wearable devices, positioning FUS alongside deep‑brain stimulation and other ablative techniques.

Data from over 200 peer‑reviewed studies indicate that patients experience an average 74% reduction in tremor amplitude at five‑year follow‑up, with functional disability improving by roughly 44%. Candidates are typically adults over 22 who have failed two first‑line drugs, exhibit unilateral or asymmetric tremor, and possess a skull density ratio sufficient for ultrasound transmission. The procedure creates a precise lesion in the ventral intermediate nucleus of the thalamus using an MRI‑compatible helmet array.

Clinicians highlighted that transient side effects—numbness, imbalance, taste disturbance, and mild dysarthria—occur in 30‑40% of cases, but most resolve within 30 days; about 10% persist mildly at one year. Patients are advised they may leave the suite with a cane or walker due to temporary balance issues. Insurance coverage is robust, with Medicare and the majority of Blue‑Cross plans reimbursing the treatment nationwide.

The significance lies in offering a durable, incision‑less alternative to deep‑brain stimulation, expanding therapeutic options for the roughly 75,000 Americans eligible for advanced ET therapies. Broad payer acceptance and favorable safety profiles suggest FUS could reshape standard care pathways for tremor management.

Original Description

Watch Johns Hopkins neurosurgeon William Anderson and neurologist Emile Moukheiber discuss how MRI-guided focused ultrasound can help patients diagnosed with essential tremor. #essentialtremor #johnshopkins #ultrasound https://www.hopkinsmedicine.org/neurology-neurosurgery/specialty-areas/movement-disorders